We have located links that may give you full text access.
Liquid Biopsy Holds Its Own in NSCLC.
Cancer Discovery 2019 March 5
According to the prospective NILE study, cell-free DNA analyses are at least as good as tissue-based genotyping for identifying therapeutically actionable genomic alterations in patients with non-small cell lung cancer; the turnaround time is also significantly shorter.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app